*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : OL5644200
CHEMICAL NAME : L-Lysine, monoacetate
CAS REGISTRY NUMBER : 57282-49-2
LAST UPDATED : 199701
DATA ITEMS CITED : 11
MOLECULAR FORMULA : C6-H14-N2-O2.C2-H4-O2
MOLECULAR WEIGHT : 206.28
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* L-Lysine acetate
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 11400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka
Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-
Volume(issue)/page/year: 23,1253,1981
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka
Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-
Volume(issue)/page/year: 23,1253,1981
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 12,933,1981
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2850 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka
Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-
Volume(issue)/page/year: 23,1253,1981
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 13400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka
Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-
Volume(issue)/page/year: 23,1253,1981
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 5100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 12,933,1981
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 5800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 12,933,1981
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 3700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka
Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-
Volume(issue)/page/year: 23,1253,1981
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 70 gm/kg/5W-I
TOXIC EFFECTS :
Blood - changes in erythrocyte (RBC) count
Nutritional and Gross Metabolic - weight loss or decreased weight gain
Biochemical - Metabolism (Intermediary) - other proteins
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 17,799,1979
*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***
NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X9114
No. of Facilities: 129 (estimated)
No. of Industries: 1
No. of Occupations: 3
No. of Employees: 4371 (estimated)
No. of Female Employees: 3309 (estimated)
*** STATUS IN U.S. ***
EPA TSCA Section 8(b) CHEMICAL INVENTORY
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
L-Lysine, N(sup6)-(N-((3-carboxyoxiranyl)carbonyl)-L-leucyl)-,hydrate
| 160825-49-0 |
LI 700
| 120528-51-0 |
Lysine, N(sup 6)-((2-chloroethoxy)carbonyl)-N(sup6)-nitroso-, L-
| 90957-40-7 |
L-Lysine, N(sup 2)-(N(sup2)-(2,2-dimethyl-1-oxohexadecyl)-L-lysyl)-, methylester, dihydrochloride
| 57746-75-5 |
Lysine, mixed with glucose
| 57746-75-5 |
L-Lysine, homopolymer, complex with 5'-cytidylicacid, homopolymer and 5'-inosinic acid, homopolymer(1:1:1)
| 64769-70-6 |
L-Lysine, N(sup2)-(N-((5-((4,6-dideoxy-4-(methylamino)-3-O-beta-D-xylopyranosyl-beta-D-galactopyranosyl)oxy)-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy -3-methyl-8,13-dioxobenzo(a)naphthacen-2-yl)carbonyl)-D-alanyl)-,(5S-trans)-
| 148676-94-2 |
L-Lysine, compd. with3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
| 83920-54-1 |
L-Lysine, compd. with3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (2:1)
| 83920-54-1 |
Lysine, N(sup6)-((4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)-, (+)-
| 992-21-2 |
l-Lysine, mixed with glucose
| 992-21-2 |
Lysine, hydrochloride, D-
| 7274-88-6 |
Leucomycin V, 12,13-dihydro-12,13-epoxy-,3,4b-diacetate 9-propanoate
| 35775-83-8 |
Liatris elegans Willd., bark, flower,fruit, leaf andstem extractSUBSTANCE DEFINITION :Plant belonging to the family CompositaeREFERENCE :TOXIA6 Toxicon. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW,UK) V.1- 1962-
| 35775-83-8 |
L-Lysine, N(sup 2)-(3-hydroxy-L-tyrosyl)-,monoacetate (salt), dihydrate
| 52370-52-2 |
L-Lysine, N(sup 6)-(iodoacetyl)-
| 90764-56-0 |
Lysine, N(sup 6)-(2-mercaptoethyl)-, hydrochloride,hydrate (3:6:1), DL-
| 53478-36-7 |
Lysine, N(sup 6)-(methoxycarbonyl)-N(sup 6)-nitroso-,L-
| 90957-39-4 |
L-Lysine, N(sup2)-((5-methyl-4-nitro-2-thienyl)carbonyl)-, methylester, monohydrochloride
| 133628-32-7 |
L-Lysine, monoacetate
| 57282-49-2 |
L-Lysine,mono((+-)-2',4'-difluoro-alpha-methyl-gamma-oxo(1,1-biphenyl)-4-butanoate)
| 161692-95-1 |
Lysine, monohydrochloride, L-
| 657-27-2 |
Lysine, monohydrochloride, L-, pyrolyzate
| 657-27-2 |
L-Lysine,mono(alpha-methyl-4-(2-methylpropyl)benzeneacetate)
| 57469-77-9 |
Libanomycin A
| 102646-78-6 |
L-Lysine,mono(alpha-methyl-4-(2-thienylcarbonyl)benzeneacetate)
| 69317-48-2 |
L-Lysine,mono(((1-(phenylmethyl)-1H-indazol-3-yl)oxy)acetate),dihydrate
| 81919-14-4 |
Lysine, monosalicylate acetate (ester), L-
| 34220-70-7 |
Lysine, monosalicylate acetate (ester), DL-
| 62952-06-1 |
Lysine,N-(1,1a,2,4,7,8,8a,8b-octahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-4,7-dioxoazirino(2',3':3,4)pyrrolo(1,2-a)indol-6-yl)-,carbamate (ester), L-
| 31854-16-7 |
D-Lysine, N(sup 2)-(N(sup2)-(1-oxohexadecyl)-D-lysyl)-, ethyl ester,dihydrochloride
| 31854-16-7 |
DL-Lysine, N(sup 2)-(N(sup2)-(1-oxohexadecyl)-DL-lysyl)-, ethyl ester,dihydrochloride
| 31854-16-7 |
L-Lysine, N(sup 2)-(N(sup2)-(1-oxohexadecyl)-L-lysyl)-, ethyl ester,dihydrochloride
| 7325-88-4 |
Lysine, N(sup 6)-(phenylacetoxy)-, benzyl ester,monohydrochloride, L-
| 6366-70-7 |
L-Lysine, sulfite (21)
| 53411-64-6 |
Libramycin A
| 51746-00-0 |
Lysoartrosi
| 39307-41-0 |
Lysobactin
| 118374-47-3 |
Lysocellin
| 55898-33-4 |
Lysocellin,3-de(carboxymethyl)-4-demethyl-17,21-dideoxy-17,21-epoxy-4-ethyl-5-hydroxy -3- methyl-, (5R)-
| 88263-35-8 |
Lysocellin,3-de(carboxymethyl)-4-demethyl-4-ethyl-5-hydroxy-3-methyl-, (5R)-
| 88263-36-9 |
Lysocellin,20-de(1-hydroxypropyl)-6-demethyl-2,6-diethyl-5-hydroxy-20-(1-hydroxybutyl )-, (2S,4S,5R)-
| 129905-10-8 |
Lysocellin,20-de(1-hydroxypropyl)-20-(1-hydroxyethyl)-
| 97671-95-9 |
Lysocellin,20-de(1-hydroxypropyl)-20-(1-hydroxyethyl)-2-methyl-,(2S)-
| 83852-59-9 |
Lysocellin, 4-demethyl-4-ethyl-5-hydroxy-, (5R)-
| 88263-37-0 |
Lysocellin, 2-methyl-, (2S)-
| 83852-60-2 |
Licheniformin
| 1392-23-0 |
Lysol
| 12772-68-8 |
Lysolecithin
| 12772-68-8 |
Lysosomes, isogenicSUBSTANCE DEFINITION :Lysosomes extracted from isogenic mouse liversREFERENCE :RFECAC Revue Francaise d'Etudes Cliniques et Biologiques. (Paris, France)V.1-14, 1956-69. For publisher information, see BIMDB3.
| 12772-68-8 |
|
|